We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth's Preventative Osteoporosis Treatment Gets Approvable Letter
Wyeth's Preventative Osteoporosis Treatment Gets Approvable Letter
April 27, 2007
The FDA sent Wyeth an approvable letter for its postmenopausal osteoporosis prevention product, bazedoxifene, April 24.